ArticleFrontiers in medicine2023

Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study.

Lin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.